查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1602782

抗衰老治疗市场：按治疗类型、最终用户、分销管道划分 - 全球预测 2025-2030

Anti-Ageing Treatment Market by Treatment Type (Abdominoplasty, Acne Treatment, Anti-Pigmentation), End User (40 Years and above, Below 25 Years, Between 25 and 40), Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

据预测，2023年抗衰老治疗市场价值为479.2亿美元，预计到2024年将达到503亿美元，复合年增长率为5.06%，到2030年将达到677.3亿美元。

调查方法包括旨在减少或预防皱纹、细纹和老年斑等明显老化迹象的各种产品和技术。这包括乳霜和精华液等局部治疗、肉毒桿菌和填充剂等侵入性手术，以及雷射治疗和微晶换肤等先进技术。这些治疗的需求主要是由于社会标准和预期寿命的延长，人们对更年轻外表的渴望不断增加。这些疗法适用于广泛的人群，但特别是针对想要保持年轻外观的中老年人。主要的最终用途领域包括皮肤科诊所、健康中心和 DIY 家庭解决方案。

主要市场统计
基准年[2023] 479.2亿美元
预测年份 [2024] 503亿美元
预测年份 [2030] 677.3亿美元
复合年增长率（%） 5.06%

市场成长主要是由于人们对老龄化的认识不断增强以及先进抗衰老技术的出现。此外，可支配收入的增加和优先考虑年轻外表的文化因素也对需求的成长做出了重大贡献。然而，市场扩张面临治疗成本高、潜在副作用和严格监管限制等挑战。由于夸大的主张和不切实际的期望导致幻灭，人们对某些治疗方法的有效性也普遍持怀疑态度。

儘管存在这些挑战，但利用天然成分和微创技术开发新型治疗方法的机会仍然存在，以满足对更安全、整体解决方案不断增长的需求。利用人工智慧和遗传学根据个人需求客製化抗衰老方案的个人化治疗创新显示出巨大的潜力。抗衰老治疗市场充满活力，受到快速技术进步和消费者偏好转向不仅保证功效、而且保证永续性和道德采购的产品的推动。为了消除消费者的怀疑，公司和研究人员应专注于严格的功效研究和透明的沟通，同时确保创新和道德市场实践之间的平衡，重点应放在开发具有成本效益的解决方案以吸引更多消费者。

市场动态：揭示快速发展的抗衰老治疗市场的关键市场洞察

供需的动态交互作用正在改变抗衰老治疗市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 老年人口数量和整容手术数量增加
    • 製造过程中的研究和临床开发
    • 提高消费者的美容意识
  • 市场限制因素
    • 抗衰老产品高成本且潜在的产品副作用
  • 市场机会
    • 增强人体皮肤弹性和紧緻度的技术进步
    • 高研发投入
  • 市场问题
    • 政府对治疗和治疗的严格规定

波特五力：驾驭抗老治疗市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点，避免潜在的挑战，确保更强大的市场地位。

PESTLE分析：了解抗衰老治疗市场的外部影响

外部宏观环境因素在塑造抗衰老治疗市场的表现动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解抗老治疗市场的竞争格局

抗衰老治疗市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：抗老治疗市场供应商的绩效评估

FPNV定位矩阵是评估抗老化治疗市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製抗老治疗市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，抗衰老治疗市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1.市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 人口老化加剧和整容手术增加
      • 生产过程中研究与临床运动的出现
      • 消费者美容意识不断增强
    • 抑制因素
      • 抗衰老产品高成本且潜在的产品副作用
    • 机会
      • 增加人体皮肤弹性和紧緻度的技术进步
      • 大量投资于研发
    • 任务
      • 关于程序和治疗的严格政府规定
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章抗老治疗市场：依治疗类型

  • 介绍
  • 腹部手术
  • 痤疮治疗
  • 抗色素沉着
  • 抗拉伸治疗
  • 皱纹治疗
  • 化学换肤
  • 眼睑手术
  • 头髮修復
  • 抽脂服务
  • 硬化疗法

第七章抗老治疗市场：依最终用户分类

  • 介绍
  • 40岁以上
  • 25岁以下
  • 25-40岁

第八章抗老治疗市场：依通路划分

  • 介绍
  • 医院/诊所
  • 豪华沙龙和水疗中心

第九章 北美和南美抗衰老治疗市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太抗老治疗市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲抗老治疗市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AbbVie, Inc.
  • Alma Lasers GmBH
  • Bausch Health Companies Inc
  • Beiersdorf AG
  • Carol Cole Company, Inc
  • Clarins Group
  • Estee Lauder Inc.
  • Galderma SA
  • L'Oreal SA
  • Mary Kay Inc.
  • Oriflame Cosmetics Global SA
  • Pierre Fabre Dermo-Cosmetique Usa, Inc.
  • Procter & Gamble Company
  • Proderma Light
  • Sinclair Pharma Group
Product Code: MRR-4358BACA7F08

The Anti-Ageing Treatment Market was valued at USD 47.92 billion in 2023, expected to reach USD 50.30 billion in 2024, and is projected to grow at a CAGR of 5.06%, to USD 67.73 billion by 2030.

The anti-ageing treatment market encompasses a variety of products and methodologies aimed at reducing or preventing the visible signs of ageing, such as wrinkles, fine lines, and age spots. This includes topical treatments like creams and serums, invasive procedures such as Botox and fillers, and advanced technologies like laser therapy and microdermabrasion. The necessity for these treatments primarily stems from the growing desire for youthful appearances, driven by societal standards and increased life expectancy. Application of these treatments spans across diverse demographics, but particularly targets middle-aged to older adults looking to maintain a youthful aesthetic. Key end-use sectors include dermatology clinics, wellness centers, and do-it-yourself home solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 47.92 billion
Estimated Year [2024] USD 50.30 billion
Forecast Year [2030] USD 67.73 billion
CAGR (%) 5.06%

Market growth is notably influenced by increasing awareness about ageing and the availability of advanced anti-ageing technologies. Additionally, rising disposable incomes and cultural factors that prioritize youthful looks significantly contribute to the growing demand. However, market expansion faces challenges from high treatment costs, potential side effects, and stringent regulatory constraints. There is also a growing skepticism about the efficacy of certain treatments due to exaggerated claims and disillusionment following unrealistic expectations.

Despite these challenges, opportunities abound in the development of novel treatments that utilize natural ingredients and minimally invasive technologies, catering to a growing demand for safer and more holistic solutions. Innovations in personalized treatments, leveraging artificial intelligence and genetics to tailor anti-ageing regimens to individual needs, show promising potential. The market for anti-ageing treatment is dynamic, driven by rapid technological advancements and shifts in consumer preferences towards products that promise not only efficacy but also sustainability and ethical sourcing. Businesses and researchers should focus on rigorous efficacy studies and transparent communication to address consumer skepticism, and on developing cost-effective solutions to capture a broader audience, ensuring a balance between innovation and ethical market practices.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Anti-Ageing Treatment Market

The Anti-Ageing Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing geriatric population coupled with rising number of cosmetic surgeries
    • Emergence of research studies and clinical movements in the production process
    • Growing awareness of beauty in consumers
  • Market Restraints
    • High cost of anti-aging products and possibility of side effects of products
  • Market Opportunities
    • Technological advancement in enhancement of human skin elasticity and tightness
    • High investment for research and development
  • Market Challenges
    • Stringent government regulations for procedure and treatments

Porter's Five Forces: A Strategic Tool for Navigating the Anti-Ageing Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Anti-Ageing Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Anti-Ageing Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Anti-Ageing Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Anti-Ageing Treatment Market

A detailed market share analysis in the Anti-Ageing Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Anti-Ageing Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Anti-Ageing Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Anti-Ageing Treatment Market

A strategic analysis of the Anti-Ageing Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Anti-Ageing Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie, Inc., Alma Lasers GmBH, Bausch Health Companies Inc, Beiersdorf AG, Carol Cole Company, Inc, Clarins Group, Estee Lauder Inc., Galderma SA, L'Oreal SA, Mary Kay Inc., Oriflame Cosmetics Global SA, Pierre Fabre Dermo-Cosmetique Usa, Inc., Procter & Gamble Company, Proderma Light, and Sinclair Pharma Group.

Market Segmentation & Coverage

This research report categorizes the Anti-Ageing Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Treatment Type, market is studied across Abdominoplasty, Acne Treatment, Anti-Pigmentation, Anti-Stretch Treatment, Anti-Wrinkle Treatment, Chemical Peel, Eyelid Surgery, Hair Restoration, Liposuction Service, and Sclerotherapy.
  • Based on End User, market is studied across 40 Years and above, Below 25 Years, and Between 25 and 40.
  • Based on Distribution Channel, market is studied across Hospitals & Clinics and Luxury Salons & Spas.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing geriatric population coupled with rising number of cosmetic surgeries
      • 5.1.1.2. Emergence of research studies and clinical movements in the production process
      • 5.1.1.3. Growing awareness of beauty in consumers
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of anti-aging products and possibility of side effects of products
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in enhancement of human skin elasticity and tightness
      • 5.1.3.2. High investment for research and development
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent government regulations for procedure and treatments
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Anti-Ageing Treatment Market, by Treatment Type

  • 6.1. Introduction
  • 6.2. Abdominoplasty
  • 6.3. Acne Treatment
  • 6.4. Anti-Pigmentation
  • 6.5. Anti-Stretch Treatment
  • 6.6. Anti-Wrinkle Treatment
  • 6.7. Chemical Peel
  • 6.8. Eyelid Surgery
  • 6.9. Hair Restoration
  • 6.10. Liposuction Service
  • 6.11. Sclerotherapy

7. Anti-Ageing Treatment Market, by End User

  • 7.1. Introduction
  • 7.2. 40 Years and above
  • 7.3. Below 25 Years
  • 7.4. Between 25 and 40

8. Anti-Ageing Treatment Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Hospitals & Clinics
  • 8.3. Luxury Salons & Spas

9. Americas Anti-Ageing Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Anti-Ageing Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Anti-Ageing Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie, Inc.
  • 2. Alma Lasers GmBH
  • 3. Bausch Health Companies Inc
  • 4. Beiersdorf AG
  • 5. Carol Cole Company, Inc
  • 6. Clarins Group
  • 7. Estee Lauder Inc.
  • 8. Galderma SA
  • 9. L'Oreal SA
  • 10. Mary Kay Inc.
  • 11. Oriflame Cosmetics Global SA
  • 12. Pierre Fabre Dermo-Cosmetique Usa, Inc.
  • 13. Procter & Gamble Company
  • 14. Proderma Light
  • 15. Sinclair Pharma Group

LIST OF FIGURES

  • FIGURE 1. ANTI-AGEING TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. ANTI-AGEING TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ANTI-AGEING TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ANTI-AGEING TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ANTI-AGEING TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ANTI-AGEING TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ANTI-AGEING TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ANTI-AGEING TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANTI-AGEING TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANTI-AGEING TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ANTI-AGEING TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ANTI-AGEING TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANTI-AGEING TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANTI-AGEING TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY ABDOMINOPLASTY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY ACNE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY ANTI-PIGMENTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY ANTI-STRETCH TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY ANTI-WRINKLE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY CHEMICAL PEEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY EYELID SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY HAIR RESTORATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY LIPOSUCTION SERVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY SCLEROTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY 40 YEARS AND ABOVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY BELOW 25 YEARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY BETWEEN 25 AND 40, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY LUXURY SALONS & SPAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ANTI-AGEING TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES ANTI-AGEING TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC ANTI-AGEING TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. INDONESIA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. JAPAN ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. MALAYSIA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. PHILIPPINES ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. SINGAPORE ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. SOUTH KOREA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. TAIWAN ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. THAILAND ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. VIETNAM ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA ANTI-AGEING TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. DENMARK ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. EGYPT ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. FINLAND ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. FRANCE ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. GERMANY ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. ISRAEL ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. ITALY ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. NETHERLANDS ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. NIGERIA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. NORWAY ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. POLAND ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. QATAR ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. RUSSIA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. SAUDI ARABIA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH AFRICA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. SPAIN ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. SWEDEN ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. SWITZERLAND ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. TURKEY ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED ARAB EMIRATES ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED KINGDOM ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 152. ANTI-AGEING TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 153. ANTI-AGEING TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023